Postmenopausal Osteoporosis
📧 Sign up to get email alerts when something new happens for Postmenopausal Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Study of the Impact of Mother-of-pearl Nutritional Supplementation on the Prevention of Post-menopausal Osteoporosis [NA]
This clinical trial evaluates whether mother-of-pearl nutritional supplementation can prevent postmenopausal osteoporosis. It is currently r…
-
FDA approval · 2025-05-30FDA Approved: PROLIA — Supplemental Application (Amgen, Inc)
The FDA approved a supplemental application for PROLIA (denosumab) submitted by Amgen, authorizing changes to the drug's labeling. This acti…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBOND [Phase 3]
Phase 3 multicenter trial of ALVOBOND in postmenopausal osteoporosis has completed. Results have been posted.
-
CLINICAL_TRIALS withdrawal · 2025-05-25Clinical Trial Update: Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis [NA]
A clinical trial evaluating a novel resistance exercise for individuals with osteoporosis/osteopenia has been withdrawn from the registry.
-
EMA approval · 2025-05-20EMA Authorised: Conbriza (bazedoxifene) — Pfizer Europe MA EEIG
EMA authorised Conbriza (bazedoxifene) for postmenopausal osteoporosis. The marketing authorization holder is Pfizer Europe MA EEIG.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Dried Plums and Bone Health in Postmenopausal Women [NA]
This entry reports a Penn State University clinical trial evaluating the effect of dried plums on bone health in postmenopausal women; the s…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone [Phase 4]
Phase 4 clinical trial update evaluating adding abaloparatide to ongoing denosumab therapy versus continued denosumab alone in postmenopausa…
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: Sequential Therapies After Osteoanabolic Treatment
This clinical trial update at 424 General Military Hospital is recruiting to study sequential therapies following osteoanabolic treatment fo…
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)
A clinical trial comparing single or repeated zoledronic acid to alendronate following denosumab in postmenopausal osteoporosis is currently…
-
FDA approval · 2025-04-22FDA Approved: PREMPRO — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for Prempro (conjugated estrogens and medroxyprogesterone acetate) submitted by Wyeth/Pfizer to …
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: Cushing's Osteoporosis Specificities
A completed clinical trial update describing osteoporosis associated with Cushing's syndrome and osteoporosis in postmenopausal women.
-
EMA approval · 2025-04-01EMA Authorised: Evista (raloxifene hydrochloride) — Substipharm
EMA has authorised Evista (raloxifene hydrochloride) for postmenopausal osteoporosis; the marketing authorisation holder is Substipharm.
-
FDA approval · 2025-03-28FDA Approved: TYMLOS — Supplemental Application (Radius Health, Inc.)
FDA approved a supplemental application for TYMLOS (abaloparatide) by Radius Health, Inc. The approval expands the product's labeling for os…
-
CLINICAL_TRIALS research · 2025-03-27Clinical Trial Update: To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture [Phase 3]
A Phase 3 trial evaluating Abaloparatide Injection (QLG2128) for osteoporosis in postmenopausal women at high fracture risk; the study statu…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: A Study to Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis. [Phase 3]
Phase 3 trial comparing MB09 to Prolia in postmenopausal osteoporosis completed; results on efficacy, PK/PD, safety, and immune measurements…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: A Study of Amorphous Calcium Carbonate in Postmenopausal Women [NA]
This document reports an ongoing clinical trial evaluating amorphous calcium carbonate in postmenopausal women with osteoporosis to assess e…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With Osteoporosis [Phase 3]
Phase 3 trial evaluating efficacy, pharmacodynamics, safety, and immunogenicity of FKS518 in postmenopausal osteoporosis has completed, and …
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: Clinical Efficacy and Safety Comparative Study Between CMAB807 Injection and Prolia® . [Phase 3]
A Phase 3 randomized trial comparing CMAB807 injection to Prolia for efficacy and safety in postmenopausal osteoporosis has completed.
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Efficacy of OsteoBor in Postmenopausal Osteoporosis [Phase 2]
A Phase 2 clinical trial investigating the efficacy of OsteoBor in postmenopausal osteoporosis. The study status is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-02-03Clinical Trial Update: A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With Osteoporosis [Phase 3]
Phase 3 clinical trial evaluating the efficacy, safety, and immunogenicity of 9MW0311 in postmenopausal women with osteoporosis is currently…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Nutritional Supplement and Bone Health in Post-Menopausal Women [NA]
A completed clinical trial sponsored by the University of Limerick evaluating a nutritional supplement for bone health in postmenopausal wom…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Milk Protein and Bone Health in Postmenopausal Women [NA]
The record documents a completed clinical trial evaluating milk protein for bone health in postmenopausal women, sponsored by the University…
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: DPP4-Inhibitors and Bone Metabolism in Diabetes [Phase 3]
Phase 3 trial update reporting completion of a study evaluating DPP-4 inhibitors and bone metabolism in adults with type 2 diabetes, includi…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: A Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosis [Phase 3]
Phase 3 study comparing SB16, a proposed denosumab biosimilar, to Prolia in postmenopausal osteoporosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: MAGnesium Effect With ANtiosteoporotic Drugs [Phase 2]
A Phase 2 clinical trial evaluating the effect of magnesium when given with antiosteoporotic drugs for postmenopausal osteoporosis has compl…